Anteris Technologies Global Corp.

07/29/2025 | Press release | Distributed by Public on 07/29/2025 15:20

Material Agreement (Form 8-K)

Item 1.01.
Entry into a Material Definitive Agreement.
On July 28, 2025, Anteris Technologies Global Corp. (the "Company") entered into the First Amended and Restated Master Services Agreement (the "A&R MSA") with Switchback Medical, LLC ("Switchback"), pursuant to which Switchback provides various development and manufacturing services, including engineering and testing services, pursuant to purchase orders made by the Company from time to time, at set prices per unit, and in compliance with various quality management and regulatory requirements.
Under the A&R MSA, the Company granted Switchback a limited, exclusive, revocable, non-sublicensable, fully paid-up, royalty-free license to certain of the Company's intellectual property to be used solely for the purpose of manufacturing products during the term of the A&R MSA. The Company retains all rights, title and interest in the results of any testing services, reports or data generated or provided by Switchback and to any developed intellectual property.
The A&R MSA expires on March 31, 2028, and will automatically renew for successive one-year terms unless terminated by either the Company or Switchback at least 180 days prior to the end of the then-current renewal term.
The foregoing summary of the A&R MSA does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the A&R MSA, a copy of which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ending September 30, 2025.

Anteris Technologies Global Corp. published this content on July 29, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on July 29, 2025 at 21:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]